MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

West Pharmaceutical Services Inc

Closed

SectorHealthcare

274.96 -1.29

Overview

Share price change

24h

Current

Min

271.32

Max

282.53

Key metrics

By Trading Economics

Income

8.2M

140M

Sales

38M

804M

P/E

Sector Avg

41.338

87.826

Dividend yield

0.3

Profit margin

17.406

Employees

10,600

EBITDA

19M

217M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+25.23% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.30%

2.26%

Next Earnings

12 Feb 2026

Next Dividend date

4 Feb 2026

Next Ex Dividend date

28 Jan 2026

Market Stats

By TradingEconomics

Market Cap

307M

20B

Previous open

276.25

Previous close

274.96

News Sentiment

By Acuity

34%

66%

111 / 372 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Past performance is not a reliable indicator of future results.

Related News

8 Jan 2026, 23:08 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 Jan 2026, 21:39 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 Jan 2026, 20:54 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- Update

8 Jan 2026, 20:44 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks

8 Jan 2026, 17:05 UTC

Acquisitions, Mergers, Takeovers

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 Jan 2026, 16:43 UTC

Major Market Movers

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 Jan 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8 Jan 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 Jan 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 Jan 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 Jan 2026, 22:30 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 Jan 2026, 21:53 UTC

Earnings

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 Jan 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 Jan 2026, 21:10 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 Jan 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 Jan 2026, 21:09 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 Jan 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 Jan 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 Jan 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 Jan 2026, 17:48 UTC

Earnings

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 Jan 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 Jan 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 Jan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

8 Jan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 Jan 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 Jan 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

8 Jan 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 Jan 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 Jan 2026, 15:23 UTC

Acquisitions, Mergers, Takeovers

Paramount Defends Its Hostile Bid for Warner -- Update

Peer Comparison

Price change

West Pharmaceutical Services Inc Forecast

Price Target

By TipRanks

25.23% upside

12 Months Forecast

Average 348.7 USD  25.23%

High 375 USD

Low 285 USD

Based on 12 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

10

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

213.26 / 219.27Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

111 / 372 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat